Skip to main content
Veterinary Medicines

PROTIVITY LYOPHILISATE AND SOLVENT FOR SUSPENSION FOR INJECTION FOR CATTLE

Authorised
  • Mycoplasma bovis, strain N2805-1, Live

Product identification

Medicine name:
PROTIVITY LYOPHILISATE AND SOLVENT FOR SUSPENSION FOR INJECTION FOR CATTLE
Protivity Lyophilisat und Lösungsmittel zur Herstellung einer Injektionssuspension für Rinder
Active substance:
  • Mycoplasma bovis, strain N2805-1, Live
Target species:
  • Cattle
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Mycoplasma bovis, strain N2805-1, Live
    2200000.00
    Colony forming unit
    /
    1.00
    unit(s)
Pharmaceutical form:
  • Lyophilisate and solvent for suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Cattle
      • All relevant tissues
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI02AE05
Authorisation status:
  • Valid
Authorised in:
  • Germany
Package description:
  • Cardboard box containing 1 vial with 10 doses of lyophilisate and 1 vial with 20 ml solvent.

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Zoetis Deutschland GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Zoetis Belgium
Responsible authority:
  • Paul-Ehrlich-Institut
Authorisation number:
  • PEI.V.12135.01.1
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0454/001
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • Germany
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Netherlands
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 11/04/2025